Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of RELVAR on asthma COPD overlap syndrome

Trial Profile

Effect of RELVAR on asthma COPD overlap syndrome

Phase of Trial: Phase II

Latest Information Update: 11 Dec 2014

At a glance

  • Drugs Vilanterol/fluticasone furoate (Primary) ; Salmeterol/fluticasone propionate
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Dec 2014 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 09 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top